• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Novartind Share Price

    Novartis India Share PriceNovartis India

    Small Cap 3.9k Result
    ₹716.85
    -1.35 (-0.19%)
    As on 27 September, 2023 | 10:58 BSE: 500672 NSE: NOVARTINDISIN: INE234A01025

    Novartis India Performance

    Day Range

    • Low 714
    • High 720.4
    716.85

    52 Week Range

    • Low 537
    • High 909
    716.85
    • Open Price720.2
    • Previous Close718.2
    • Volume2509

    Start SIP in Novartis India

    Start SIP

    Novartis India Share Price

    • Over 1 Month -0.58%
    • Over 3 Month -11.39%
    • Over 6 Month 25.86%
    • Over 1 Year 5.6%

    Novartis India Key Statistics

    P/E Ratio 24.8
    PEG Ratio 0.4
    Market Cap Cr 1,770
    Price to Book Ratio 2.3
    EPS 40.8
    Dividend 6.6
    Relative Strength Index 38.47
    Money Flow Index 59.55
    MACD Signal -1.43
    Average True Range 15.53

    Novartis India Investment Rating

    • Master Rating:

    • Novartis India has an operating revenue of Rs. 348.42 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 30% is great, ROE of 13% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Novartis India Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 91768010212198
    Operating Expenses Qtr Cr 736773858993
    Operating Profit Qtr Cr 179816326
    Depreciation Qtr Cr 221111
    Interest Qtr Cr 000010
    Tax Qtr Cr 8-2734-8
    Net Profit Qtr Cr 202581852-23
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 437433
    Operating Expenses Annual Cr 314373
    Operating Profit Annual in Cr 6527
    Depreciation Cr 610
    Interest Annual Cr 25
    Tax Annual Cr 120
    Net Profit Annual Cr 103-4
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 4539
    Cash from Investing Activity Annual Cr -15387
    Cash from Financing Annual Activity Cr -30-36
    Net Cash Flow Annual Cr -13990
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 776692
    Fixed Assets Annual Cr 1924
    Total Non Current Assets Annual Cr 306249
    Total Current Assets Annual Cr 677709
    Total Assets Annual Cr 983958
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 314280
    ROE Annual % 13-1
    ROCE Annual % 147
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3315
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %

    Novartis India Technicals

    EMA & SMA

    Current Price
    ₹716.85
    -1.35 (-0.19%)
    • Bullish Moving Average
    • ___
    • 3
    • Bearish Moving Average
    • ___
    • 13
    • 20 Day
    • ₹733.64
    • 50 Day
    • ₹740.16
    • 100 Day
    • ₹731.18
    • 200 Day
    • ₹709.77
    • 20 Day
    • ₹732.52
    • 50 Day
    • ₹744.39
    • 100 Day
    • ₹751.44
    • 200 Day
    • ₹686.26

    Novartis India Resistance and Support

    PIVOT
    ₹721.35
    Resistance
    First Resistance ₹725.7
    Second Resistance ₹733.2
    Third Resistance ₹737.55
    RSI 38.47
    MFI 59.55
    MACD Single Line -1.43
    MACD -2.5
    Support
    First Resistance ₹713.85
    Second Resistance ₹709.5
    Third Resistance ₹702

    Novartis India Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 12,835 772,410 60.18
    Week 15,952 831,918 52.15
    1 Month 19,539 966,192 49.45
    6 Month 36,535 1,838,829 50.33

    Novartis India Result Highlights

    Novartis India Synopsis

    NSE-Medical-Diversified

    Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 378.74 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2023. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.
    Market Cap 1,773
    Sales 348
    Shares in Float 0.72
    No of funds 43
    Yield 1.39
    Book Value 2.29
    U/D Vol ratio 1.1
    LTDebt / Equity
    Alpha 0.02
    Beta 0.36

    Novartis India

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 70.68%70.68%70.68%70.68%
    Mutual Funds
    Insurance Companies 0.74%0.76%0.76%0.76%
    Foreign Portfolio Investors 0.23%0.17%0.17%0.17%
    Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
    Individual Investors 23.09%23.04%23.01%23.02%
    Others 5.25%5.34%5.37%5.36%

    Novartis India Management

    Name Designation
    Mr. Christopher Snook Chairman
    Mr. Sanjay Murdeshwar Vice Chairman & Mng.Director
    Ms. Shilpa Joshi WholeTime Director & CFO
    Ms. Sandra Martryes Independent Director
    Mr. Jai Hiremath Independent Director
    Mr. Sanker Parameswaran Independent Director

    Novartis India Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Novartis India Corporate Action

    Date Purpose Remarks
    2023-07-26 Quarterly Results
    2023-05-10 Audited Results, Final & Special Dividend
    2023-02-08 Quarterly Results
    2022-11-09 Quarterly Results
    2022-07-27 Quarterly Results

    Novartis India MF Shareholding

    Name Amount(cr)
    Motilal Oswal S&P BSE Healthcare ETF 8
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Novartis India FAQs

    What is Share Price of Novartis India ?

    Novartis India share price is ₹716 As on 27 September, 2023 | 10:44

    What is the Market Cap of Novartis India ?

    The Market Cap of Novartis India is ₹1770 Cr As on 27 September, 2023 | 10:44

    What is the P/E ratio of Novartis India ?

    The P/E ratio of Novartis India is 24.8 As on 27 September, 2023 | 10:44

    What is the PB ratio of Novartis India ?

    The PB ratio of Novartis India is 2.3 As on 27 September, 2023 | 10:44

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.